Document:

Separation Agreement btwn Patheon and Wesley P. Wheeler dated November 30, 2010

 Exhibit 10.24 
 November 30, 2010 
 Mr. Wesley Wheeler 

1211 Village Crossing Drive 
 Chapel Hill, NC
27517 
 Re: Separation from Employment and Release of Claims 
 Dear Wes: 
 As we recently discussed, this letter confirms notice of your
separation from the position of President and Chief Executive Officer of Patheon Inc. (the “Patheon”) effective November 30, 2010 (the “Separation Date”). Effective as of the Separation Date, you shall no
longer be a member of the Board of Directors of Patheon or hold any positions as an employee, officer or director of Patheon Pharmaceutical Services Inc. (the “Corporation”) or any entity controlled by, controlling, or under common
control with the Corporation (the “Affiliated Group”) and you agree to execute such documents and take such actions as may be necessary or desirable to further effectuate the foregoing. Reference is made to the Employment Agreement
between you and the Corporation, dated December 3, 2007 as amended on May 5, 2009 (the “Employment Agreement”) and Schedule B to the Employment Agreement, dated April 16, 2008 (the “Confidentiality
Undertaking”). Except as otherwise provided herein, any of your rights under the Employment Agreement shall terminate as of the Separation Date. 
 1. Accrued Obligations. Regardless of whether you sign this agreement: 

1.1 within 30 days following the Separation Date, you will be provided with all earned, but unpaid salary through the Separation
Date, at the annualized rate of $650,000 US (the “Annual Base Salary Rate”); 
 1.2 within 30 days
following the Separation Date, you will be provided with 5 weeks accrued and unused vacation pay; 
 1.3 consistent
with Corporation policy and after submission of appropriate documentation, you will be provided with all any reasonable business expenses you incurred through the Separation Date in accordance with Corporation policy; and 

1.4 following the Separation Date, pursuant to the provisions of the Consolidated Omnibus Budget Reconciliation Act of 1985, as
amended (“COBRA”), you shall be entitled to seek continued health insurance coverage at your own expense and subject all respects to the requirements, 

 
conditions and limitations of COBRA and of Patheon’s health insurance plan, which may be amended from time to time. 
 2. Separation Payments. The termination of your employment shall be treated as a termination other than for “Cause” under your Employment Agreement. Pursuant to Section 5.4 of the
Employment Agreement, the Corporation is offering you certain separation payments and benefits set forth in Section 2 herein (the “Separation Payments”) conditional upon you executing this Agreement and agreeing to the full
waiver and release of all claims and your compliance with the other terms and conditions of this agreement. Provided that the Effective Date has occurred, in exchange for your waiver and release of all claims and your agreement to abide by the other
terms and conditions set forth herein, the Corporation will provide you with the following payments and benefits following your execution (and non-revocation pursuant to Section 6(ii)) of this agreement: 

2.1 Salary Continuation: From the Separation Date through the second anniversary of the Separation Date, you will be
provided with an amount equal to two times your annual Base Salary Rate, which will be payable in 24 equal monthly installments commencing within the 30 day period commencing on the 60th day following the Separation Date. 

2.2 Executive Incentive Performance Bonus: You will remain eligible for a 2010 incentive plan bonus payable in accordance
with the terms of the plan, which shall be determined in the sole direction of the Board of Directors of Patheon and in a manner consistent with the method used to determine incentive plan payouts of other senior executives of the Company. Such
bonus shall be payable within three months after the end of Patheon’s fiscal year relating to 2010. 
 2.3 The
“Effective Date” for purposes of this agreement shall be the eighth (8th) calendar day following the date that you sign and return this agreement to the Corporation, provided that you do not revoke or attempt to revoke your
acceptance of this agreement prior to such date in accordance with Section 6(ii) herein. 
 2.4 All amounts payable
to you under this agreement shall be less all applicable tax withholding and other authorized, statutory or legally required deductions. 
 3. Equity. Pursuant to Section 3.4 of the Employment Agreement, certain options to acquire Restricted Voting Shares of Patheon you were granted in Patheon have vested as follows: 470,000 on
December 18, 2007; 420,000 on December 18, 2008; and 420,000 on December 18, 2009. Such options will continue to be governed by Section 3.4 of the Employment Agreement and the terms of the Patheon Amended And Restated Incentive
Stock Option Plan dated September 4, 2008. You shall have no rights relating to any unvested options to acquire Restricted Voting Shares of Patheon. 
 4. Continuing Obligations. You acknowledge and agree that your covenant not to compete and other obligations set forth in Article 6 of the Employment Agreement, Section 7.9 of the Employment
Agreement and the Confidentiality Undertaking continue following the Separation Date. You further acknowledge and agree that the terms of this agreement are to be treated as confidential information under the Confidentiality Undertaking. 

  
 2 

 5. Waiver and Release. 

5.1 Waiver and Release of all Claims By You. In consideration for the covenants and agreements set forth herein, the sufficiency
of which you hereby acknowledge, you, on behalf of yourself and your successors, assigns, executors and administrators, voluntarily, knowingly and willingly release and forever discharge the Corporation, the Affiliated Group and JLL Partners, Inc.,
together with each of their respective past and present parents, subsidiaries, and affiliates, together with each of their officers, directors, stockholders, partners, employees, agents, representatives, attorneys and their respective advisors and
each of their subsidiaries, affiliates, estates, predecessors, successors, and assigns (collectively, the “Releasees”) from any and all rights, claims, charges, actions, causes of action, complaints, sums of money, suits, debts,
covenants, contracts, agreements, promises, obligations, damages, demands or liabilities of every kind whatsoever, in law or in equity, whether known or unknown, suspected or unsuspected (collectively, “Claims”) which you or your
executors, administrators, successors or assigns ever had, now has or may hereafter claim to have by reason of any matter, cause or thing whatsoever, arising from the beginning of time up to the date of this agreement including, but not limited to:
(i) any Claims arising under any foreign, federal, provincial, local, state, territory or commonwealth statute, constitution or regulation, including, without limitation, the Age Discrimination in Employment Act (ADEA), the Older Workers
Benefit Protection Act (OWBPA), the Fair Labor Standards Act, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act of 1990, the Employee Retirement Income Security Act of 1974, the Sarbanes-Oxley Act of 2002, the Worker
Adjustment and Retraining Notification Act, the Rehabilitation Act of 1973, Executive Order 11246, the Family and Medical Leave Act of 1993, and/or the applicable foreign, federal, provincial, local, state, territory or commonwealth law against
discrimination; (ii) Claims relating to your hiring, your employment or your cessation of employment with the Corporation, the Affiliated Group or any of the Releasees, as well as the circumstances thereof; and (iii) Claims arising under
or relating to any policy, agreement, understanding or promise, written or oral, formal or informal, between the Corporation, the Affiliated Group and any of the Releasees and you existing as of the date of this agreement, including, but not limited
to, the Employment Agreement. This Section 5.1 does not waive or attempt to waive (i) any Claims that cannot legally be waived; (ii) any rights you may have to file a charge with a federal or state administrative agency in the United
States; provided, however, that you acknowledge and agree that, you are not entitled to any personal recovery in any such agency proceedings; (iii) any Claims you may have under this agreement; (iv) any rights you may have to
defenses and indemnity under any certificate, bylaw, resolution, policy or practice of the Corporation; (v) any rights you may have under any liability insurance as provided by the Corporation; and (vi) any vested benefits you may have,
subject to the terms of the plan documents. 
 5.2 Your Waiver and Release Includes Unknown Claims. For the purpose of
implementing a full and complete release, you understand and agree that this release of claims is intended to include all claims, if any, which you may have and which you do not now know or suspect to exist in your favor against the Releasees and
that this agreement extinguishes those claims. Accordingly, you expressly waive all rights afforded by any state statute or regulation in any applicable jurisdiction prohibiting, limiting, or restricting the waiver of unknown claims. 

  
 3 

 5.3 No Other Claims. By signing this Agreement, you represent and warrant that you
have not commenced or joined in any Claim whatsoever against any of the Releasees arising out of or relating to any of the matters set forth in Section 5.1 above. 
 5.4 No Further Rights Or Benefits. You acknowledge and agree that, other than as specifically provided above in this Agreement, you are not entitled to any compensation, rights or amounts under the
Employment Agreement or any contract, plan, policy or practice, past or present, of the Corporation, the Affiliated Group or any of the other Releasees. Except as set forth above, you acknowledge and agree that as of the Separation Date, you shall
not be eligible to participate or continue to participate in any employee benefit plans or compensation arrangements of the Corporation, the Affiliated Group or any of the other Releasees or otherwise be entitled to any perquisite or fringe benefit.

 6. Review and Revocation. You understand and agree that you are waiving your rights under the ADEA and the OWBPA and,
in accordance with those statutes, you have been informed and you understand and agree that: (i) you have fifty (50) calendar days after receipt of this agreement to consider whether to sign it; (ii) you may revoke this agreement in
writing (notice to Patheon Human Relations Department) at any time during the seven (7) calendar days after this agreement is signed by you, in which case none of the provisions of this agreement will have any effect; (iii) you have been
advised to consult with an attorney of your choice concerning the legal consequences of this agreement; (iv) you are not waiving, releasing, or otherwise discharging any claims under the ADEA that may arise after the date you sign this
agreement; and (v) the Separation Payments provided herein constitute consideration beyond which you would be entitled to receive but for your execution (and non-revocation) of this agreement. 

7. Non-Disparagement. 
 7.1 Your Obligation. You agree that you will not, will fully at any time, make, directly or indirectly, any oral or written public statements that are disparaging of the Corporation, the Affiliated
Group or JLL Partners, Inc., or any of their respective affiliates or subsidiaries, products or services, or present or former officers, directors, partners, stockholders or employees. The Corporation, the Affiliated Group, or JLL Partners, Inc.
agree that the members of the Board of Directors and Executive Committee will not willfully, at any time, make, directly or indirectly, any oral or written public statements that are disparaging of you. 

7.2 Responding to Legal Process. Nothing in this agreement shall prohibit you from responding to a valid subpoena, court order or
similar legal process; provided, however, that prior to you responding to a valid subpoena, court order or similar legal process which may require the disclosure of confidential information, you shall provide the Corporation, the
Affiliated Group and JLL Partners, Inc. with written notice of the subpoena, court order or similar legal process sufficiently in advance of such disclosure to afford such entity a reasonable opportunity to challenge the subpoena, court order or
similar legal process. 
 8. Return of Affiliated Group Property. You agree that you shall promptly, and in any event
within three (3) business days of the Separation Date, return to the Corporation all of the 

  
 4 

 
Affiliated Group’s property and all documents and materials that in any way incorporate, reflect or constitute the Affiliated Group’s confidential and proprietary information and/or
trade secrets, provided however, that you may retain your Blackberry with existing phone numbers and the contacts list contained in your Outlook data file. 
 9. 409A Compliance. Section 7.8 of the Employment Agreement is incorporated by reference as if restated herein. However, for the avoidance of doubt, all amounts payable to you under this
agreement shall be treated as set forth in Section 2.4 herein. 
 10. Entire Agreement. Except as specifically
provided herein, this agreement constitutes the complete, final and exclusive embodiment of the entire agreement between you, the Corporation and the Affiliated Group with regard to its subject matter. It is entered into without reliance on any
promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations, including those set forth in the Employment Agreement. This agreement may not be
modified or amended except in a writing signed by both you and a duly authorized officer of the Corporation. This agreement shall bind the heirs, personal representatives, successors and assigns of both you and the Corporation, and inure to the
benefit of both you and the Corporation, their heirs, successors and assigns. 
 11. Representations. You acknowledge and
agree that, if you choose to sign this agreement, that it is executed voluntarily and without any duress or undue influence on the part of the Corporation or the Affiliated Group. You further acknowledge that, prior to executing this agreement, that
you read this agreement and fully understood the terms and consequences of this agreement and of the release it contains and that you had the opportunity to consult with legal counsel of your own choice prior to executing the agreement. 

12. No Admission of Liability. You understand and acknowledge that this agreement constitutes a compromise and settlement of any
and all potential disputed claims. No action taken by the Corporation or the Affiliated Group hereto, either previously or in connection with this agreement, shall be deemed or construed to be: (a) an admission of the truth or falsity of any
potential claims; or (b) an acknowledgment or admission by the Corporation or the Affiliated Group of any fault or liability whatsoever to you or to any third party. 
 13. Severability. If any provision of this agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this agreement and
the provision in question shall be modified by the court so as to be rendered enforceable. 
 14. Governing Law. This
agreement shall be deemed to have been entered into and shall be construed and enforced in accordance with the laws of the State of New York without regard to its conflicts of law principles. In the event a dispute arises out of or pertains to this
agreement, you and the Corporation agree to use our reasonable efforts to resolve such dispute through negotiation. In the event such dispute cannot be settled through negotiation, we agree that any action or proceeding instituted with respect
thereto shall be commenced and maintained exclusively in the courts of and within the State of New York, which may exercise jurisdiction over the subject matter. 

  
 5 

 15. Tax Advice and Information. You acknowledge that none of the Corporation, the
Affiliated Group or any of their representatives have provided you with any tax advice or tax-related representations concerning the payments provided for in this agreement or any other aspect of this agreement. Further, you understand and agree
that you should consult your own tax advisor(s) for any such tax advice or information. 
 16. Captions. The title and
captions used in this agreement are for convenience only and are not to be construed in interpreting this agreement. 
 If you
agree to its terms and conditions contained in this agreement, please sign below and return the original to me. We wish you the best of luck in your future endeavors. 
 Sincerely, 
  

			
	PATHEON PHARMACEUTICAL SERVICES INC.
		
	By:	 	/s/ Eric Evans
	NAME:	 	Eric Evans
	TITLE:	 	CFO

 I READ AND UNDERSTAND AND AGREE TO THE TERMS AND
CONDITIONS OF THIS AGREEMENT, SPECIFICALLY INCLUDING THE WAIVER AND RELEASE OF ALL CLAIMS AGAINST THE CORPORATION, THE AFFILIATED GROUP AND THE OTHER RELEASEES. 
  

					
	ACCEPTED AND AGREED:	 		 	
			
	/s/ Wesley Wheeler	 		 	14 December 2010
	Wesley Wheeler	 		 	Date

  
 6Employment Agreement between Patheon and Peter T. Bigelow dated Dec 31, 2009

 Exhibit 10.25 
 [PATHEON] 
  

			
		  	 Wesley P. Wheeler

Chief Executive Officer & President
 Patheon Inc
 PO Box 110145
 Research Triangle Park, NC 27709
 Phone: 919-226-3201

Fax: 919-226-3202

wes.wheeler@patheon.com

December 31, 2009 
 PRIVATE AND
CONFIDENTIAL 
 Peter T. Bigelow, P.E. 
 60 Diamond Road 
 Phoenixville, PA 19460-2780 

Dear Peter: 
 RE: Employment Agreement:
President, North American Operations 
 I am pleased to confirm the terms of your employment (“Employment Agreement”). This
Employment Agreement represents your contractual arrangements with Patheon Pharmaceutical Services Inc. (the “Corporation”) and supersedes any arrangements, understandings and verbal commitments to you during our discussions. 

Sincerely, 
 /s/ Wesley P. Wheeler 

Wesley P. Wheeler 
 Chief Executive Officer

 [PATHEON] 
 EMPLOYMENT AGREEMENT 
 THIS AGREEMENT is made as of the 31st day of
December, 2009 between Patheon Pharmaceutical Services Inc. (the “Corporation”) and Peter Bigelow, an Executive residing in the City of Phoenixville, in the State of Pennsylvania (the “Executive”).

 WHEREAS, the Corporation and the Executive wish to enter into this Agreement to set forth the rights and obligations of each
of them with respect to the employment of the Executive. 
 WHEREAS, the Corporation agrees to employ the Executive on the terms
and subject to the conditions set forth in this Agreement to render exclusive and full-time services to the Affiliated Group (as defined below). 
 NOW, THEREFORE, THIS AGREEMENT WITNESSES that in consideration of the premises and mutual covenants and agreements hereinafter contained and other good and valuable consideration (the receipt and
sufficiency of which is hereby acknowledged), the parties agree with each other as follows: 
 ARTICLE 1 

INTERPRETATION 
  

	1.1	Governing Law. This Agreement shall be construed and interpreted in accordance with the laws of the State of North Carolina. Each of the parties hereby
irrevocably consents to the jurisdiction of the courts in the State of North Carolina with respect to any matters arising out of this Agreement. 

  

	1.2	Definitions. In this Agreement, including Schedule A and B hereto, unless the context otherwise requires, the following terms shall have the following
meanings, respectively: 

  

	 	(a)	“Affiliated Group” means the Corporation and any entity controlled by, controlling, or under common control with the Corporation.

  

	 	(b)	“Agreement” means this Employment Agreement as it may be amended or supplemented from time to time. 

 

	 	(c)	“Annual Base Salary” has the meaning given such term in Section 3.1. 

 

	 	(d)	“Board of Directors” means the Board of Directors of Patheon. 

 

	 	(e)	“Cause” means the determination, in good faith, by the Board of Directors, after notice to the Executive and, if curable, a reasonable opportunity to
cure, that one or more of the following events has occurred: (i) the Executive has failed to perform his material duties. and such failure has not been cured after a period of 30 days notice from the Corporation; (ii) any reckless or
grossly negligent act by the Executive having the effect of injuring the interests, business or reputation of any member of the Affiliated Group in any material respect; (iii) the Executive’s commission of any felony (including entry of a
nolo contendere plea): (iv) any misappropriation or embezzlement of the property of any member of the Affiliated 

  
 Page 2

 Group; or (v) a breach of any material provision of this Agreement by the Executive.

  

	 	(f)	“Change in Control” means any of the following events: 

  

	 	(i)	Any “Person” (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”)), other than JLL Partners or its affiliates, becomes a Beneficial Owner (within the meaning of Exchange Act Rule 13d-3) of more than fifty percent (50%) of the voting power of the then outstanding voting securities of Patheon
entitled to vote generally in the election of directors; 

  

	 	(ii)	There is consummated a merger or consolidation of Patheon or any direct or indirect subsidiary of Patheon with any other company, other than a merger or consolidation
that would result in the voting securities of Patheon outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or any
parent thereof) at least fifty percent (50%) of the combined voting power of the securities of Patheon or such surviving entity or any parent thereof outstanding immediately after such merger or consolidation; or 

 

	 	(iii)	The stockholders of Patheon approve a plan of complete liquidation or dissolution of the company or there is consummated an agreement for the sale or disposition by
Patheon of all or substantially all of its assets. 

  

	(g)	“Code” means the Internal Revenue Code of 1986, as amended. 

 

	(h)	“Competitor” has the meaning given such term in Section 6.4. 

 

	(i)	“Date of Termination” has the meaning given such term in Section 4.5. 

 

	(j)	“Effective Date” has the meaning given such term in Section 2.1. 

 

	(k)	“Good Reason” means the occurrence of any of the following events without the consent of the Executive: (i) a material reduction by the
Corporation of the Executive’s duties or responsibilities or the assignment to the Executive of duties or responsibilities materially inconsistent with the Executive’s position; or (ii) a material breach by the Corporation of this
Agreement; or (iii) requirement by the Corporation that the Executive work more than fifty (50) miles from Executive’s principle office upon commencement of Employment. A termination of the Executive’s employment by Executive
shall not be deemed to be for Good Reason unless (i) the Executive gives notice to the Corporation of the existence of the event or condition constituting Good Reason within 30 days after such event or condition initially occurs or exists,
(ii) the Corporation fails to cure such event or condition within 30 days after receiving such notice, and (iii) the Executive’s “separation from service” within the meaning of Section 409A of the Code occurs not later
than 90 days after such event or condition initially occurs or exists. 

  

	(l)	“Patheon” means Patheon Inc. 

  

	(m)	“Target Bonus” has the meaning given such term in Section 3.2. 

  
 Page 3

 ARTICLE 2 
 EFFECTIVE DATE; TERMS OF EMPLOYMENT 
  

	2.1	Term 

 The
Corporation hereby agrees to employ the Executive, and the Executive hereby agrees to be employed by the Corporation on the terms and subject to the conditions of this Agreement (including, without limitation. Article 6), commencing on start date
(the “Effective Date”). 
  

	2.2	Position and Duties 

The Executive shall serve as the President, North American Operations, with such authority, duties and responsibilities as are
commensurate with such position, reporting to the Chief Executive Officer. 
 The Executive shall also be responsible for the
functions and responsibilities set out in the Position Description for the President, North American Operations attached as Schedule A. 
  

	2.3	Time Commitments 

During the Executive’s employment, the Executive shall devote substantially all of his business time, energies and talents to serving
as the President, North American Operations, perform his duties conscientiously and faithfully subject to the reasonable and lawful directions of the Chief Executive Officer, and in accordance with each of the corporate governance and ethics
guidelines, conflict of interests policies and code of conduct applicable to all employees or senior executives generally of the Affiliated Group. During the Executive’s employment, it shall not be a violation of this Agreement for the
Executive, subject to the requirements of Article 6, to (a) fulfill speaking engagements and (b) manage personal investments, so long as such activities do not materially interfere with the performance of the Executive’s duties or
responsibilities under this Agreement. 
 ARTICLE 3 

COMPENSATION AND BENEFITS 
  

	3.1	Base Salary 

 The
Corporation shall pay the Executive an annualized base salary (“Annual Base Salary”) at a rate of not less than $ 425,000 US, payable in regular installments in accordance with the Corporation’s normal payroll practices. The Annual
Base Salary shall be reviewed by the Chief Executive Officer, for increase only, at such time as the salaries of other senior executives of Patheon are reviewed generally. If so increased, the Annual Base Salary shall be increased for all purposes
of this Agreement. 
  

	3.2	Executive Performance Bonus 

 For each fiscal year, the Executive shall be eligible to participate in an annual incentive plan under terms and conditions no less favorable than other senior executives of Patheon; provided that the
Executive’s Target Bonus shall not be less than 45% of his Annual Base Salary. The Executive’s payment under the annual incentive plan shall be 

  
 Page 4

 
based on meeting predetermined personal objectives and Patheon’s financial performance. The personal objectives will be set by the Chief Executive Officer, and the financial performance
measures will be set by the Chief Executive Officer. For fiscal 2010, the performance bonus will be prorated from the Effective Date. The annual performance bonus, if earned, will be paid to the Executive by the Corporation in the same manner and
payment period generally applicable under the annual incentive plan, but in no event later than two and a half months after the later of (i) the end of the applicable performance period, or (ii) the end of the calendar year in which the
performance period ends. Nothing contained in this Section 3.2 will guarantee the Executive any specific amount of incentive compensation, or prevent the Chief Executive Officer from establishing performance goals and compensation targets
applicable only to the Executive. 
  

	3.3	Sign-on Bonus  

The Corporation will pay the Executive in a lump sum, within 30 business days of the Effective Date, a sign-on bonus of $ 100,000 U.S. If
Executive voluntarily terminates employment with the Corporation within one year after the Effective Date, Executive shall reimburse the Corporation this $ 100,000 payment within 30 days of termination. If Executive fails to make this reimbursement
payment within 30 days of termination, the Corporation shall withhold the unpaid amount from any amounts otherwise owed to the Executive (but only to the extent those amounts are not considered deferred compensation under Section 409(A).

  

	3.4	Stock Options  

  

	 	(a)	Subject to the approval of the Board of Directors, the Executive shall be granted a stock option to purchase 200,000 shares of common stock of Patheon at an exercise
price per share equal to the market value of the common stock on the date of the grant (the “Option”). Except as otherwise provided in the Amended and Restated Incentive Stock Option Plan (the “ISOP”) or stock option award
agreement (together with the ISOP, the “Stock Related Documents”), the Option will (i) vest as to 1/3 of the shares subject to the Option on each of the first three anniversaries of the date of grant, subject to the Executive’s
continued employment with the Affiliated Group until the relevant vesting dates, and (ii) have a seven year term. The Option will be subject to the terms, definitions and provisions of the applicable Stock Related Documents.

  

	 	(b)	During the Executive’s employment, at the discretion of the Board of Directors or its delegate, the Executive also shall be eligible to receive additional stock
options and other long-term incentives under the ISOP or any similar plan adopted by Patheon from time to time. 

  

	 	(c)	The Executive will be required to comply with the terms of any share ownership guidelines applicable to senior executives of Patheon generally, as amended from time to
time. 

  

	3.5	Retirement Benefits 

Executive will be entitled to participate in the 401(k) retirement plan and any other qualified or nonqualified deferred compensation and
retirement plans applicable to senior executives of the Corporation generally, in each case as amended from time to time. 

  
 Page 5

	3.6	Other Benefit Plans 

The Executive’s principal office will be at the US Headquarters location in Durham, North Carolina. The Executive will be required to
relocate to Raleigh/Durham area as a condition employment. The Executive will be eligible for relocation assistance in accordance with the attached North American Tier 1 program. The move must be completed within 12 months of Executive’s
employment. Notwithstanding anything to the contrary in the North American Tier 1 program, Executive shall be entitled to reimbursement for temporary living accommodations for up to a maximum of 12 months. 

During the Executive’s employment, the Executive also shall be entitled to participate in all welfare, perquisites, fringe benefit,
and other benefit plans, practices, policies and programs, as may be in effect from time to time, for U.S. resident-based senior executives of Patheon generally. 
 The Corporation shall also pay the Executive, in regular semi-monthly installments, an allowance of $ 1,200 allowance for level US per month for car related expenses. 

 

	3.7	Expenses 

 The
Executive shall be reimbursed for all reasonable travel and other out-of-pocket expenses actually and properly incurred by the Executive during the Executive’s employment in connection with carrying out his duties hereunder in accordance with
the Corporation’s policies, as may be in effect from time to time, for its senior executives generally. 
  

	3.9	Vacation 

 During
the Executive’s employment, the Executive shall be entitled to four (4) weeks paid vacation in addition to four (4) floating holidays annually in accordance with the Corporation’s policies, as may be in effect from time to time,
for its senior executives generally. 
 ARTICLE 4 
 TERMINATION OF EMPLOYMENT 
  

	4.1	Death or Disability 

The Executive’s employment shall terminate automatically upon the Executive’s death. If the Corporation determines in good faith
that the Disability (as defined below) of the Executive has occurred during the Executive’s employment, it may give to the Executive written notice in accordance with Section 7.4 of this Agreement of its intention to terminate the
Executive’s employment; provided that such notice is provided no later than 150 days following the Executive’s first day of Disability. In such event, the Executive’s employment shall terminate effective on the 30th day after receipt
of such notice by the Executive (the “Disability Effective Date”), provided that, within the 30 days after such receipt, the Executive shall not have returned to full-time performance of the Executive’s duties. For purposes of this
Agreement, “Disability” shall mean the failure of the Executive to perform his duties under this Agreement for at least 90 consecutive business days as a result of any medically determinable physical or mental impairment. The determination
of Disability shall be made by a physician selected by the Corporation 

  
 Page 6

 
or its insurers and reasonably acceptable to the Executive or the Executive’s legal representative. 
  

	4.2	Cause 

 The
Executive’s employment with the Corporation may be terminated with or without Cause. 
  

	4.3	Good Reason  

 The
Executive’s employment with the Corporation may be terminated by the Executive with or without Good Reason. 
  

	4.4	Notice of Termination 

 Any termination by the Corporation for Cause, or by the Executive for Good Reason, shall be communicated by Notice of Termination to the other party in accordance with Section 7.4. For purposes of
this Agreement, a “Notice of Termination” means a written notice which (a) indicates the specific termination provision in this Agreement relied upon, (b) to the extent applicable, sets forth in reasonable detail the facts and
circumstances claimed to provide a basis for termination of the Executive’s employment under the provision so indicated and (c) if the Date of Termination (as defined below) is other than the date of receipt of such notice, specifies the
termination date (which date shall be not more than 30 days after the giving of such notice). The failure by the Corporation or the Executive to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Cause
or Good Reason shall not waive any right of the Corporation or the Executive, respectively, hereunder or preclude the Corporation or the Executive, respectively, from asserting such fact or circumstance in enforcing the Corporation’s or the
Executive’s rights hereunder. 
  

	4.5	Date of Termination 

“Date of Termination” means (a) if the Executive’s employment is terminated by the Corporation for Cause, or by the
Executive for Good Reason, the date of receipt of the Notice of Termination or any later date specified therein, as the case may be, (b) if the Executive’s employment is terminated by the Corporation other than for Cause or Disability, the
Date of Termination shall be the date on which the Corporation notifies the Executive of such termination and (c) if the Executive’s employment is terminated by reason of death or Disability, the Date of Termination shall be the date of
death of the Executive or the Disability Effective Date, as the case may be. The Corporation and the Executive shall take all steps necessary (including with regard to any post-termination services by the Executive) to ensure that any termination
described in this Section 4.5 constitutes a “separation from service” within the meaning of Section 409A of the Code, and the date on which such separation from service takes place shall be the “Date of Termination.”

  

	4.6	Resignation from All Positions 

 Notwithstanding any other provision of this Agreement, upon the termination of the Executive’s employment for any reason, unless otherwise requested by the Board of Directors, the Executive shall
immediately resign as of the Date of Termination from all positions that he holds or has ever held with the Affiliated Group (and with any other 

  
 Page 7

 
entities with respect to which the Affiliated Group has requested the Executive to perform services). The Executive hereby agrees to execute any and all documentation to effectuate such
resignations upon request by the Corporation, but he shall be treated for all purposes as having so resigned upon termination of his employment, regardless of when or whether he executes any such documentation. 

ARTICLE 5 

OBLIGATIONS OF CORPORATION UPON TERMINATION 
  

	5.1	Good Reason; Other than for Cause 

 If the Corporation shall terminate the Executive’s employment other than for Cause, or if the Executive shall terminate the Executive’s employment for Good Reason: 

 

	 	(a)	The Corporation shall pay, or cause to be paid, to the Executive in a lump sum in cash the sum of: (i) the Executive’s Annual Base Salary through the Date of
Termination, and (ii) any accrued vacation pay, in each case to the extent not theretofore paid (the sum of the amounts described in clauses (i) and (ii) shall be hereinafter referred to as the “Accrued Obligations”). The
Accrued Obligations shall be paid within 30 days after the Date of Termination. 

  

	 	(b)	The Corporation shall pay, or cause to be paid, to the Executive an amount equal to the Executive’s Annual Base Salary plus an amount determined by the Board of
Directors in its sole discretion to reflect the annual incentive the Executive would have otherwise earned during the year in which the Date of Termination occurs. Such amount shall generally be paid in cash in twelve equal monthly installments
beginning within 60 days after the Date of Termination or such later date set forth in Section 7.8. Notwithstanding the foregoing, if the severance benefit described in this Section 5.1(b) exceeds two times the lesser of (i) the
Executive’s annual compensation or (ii) the compensation limit in effect under Section 401(a)(17) of the Code for the calendar year including the Date of Termination, any amounts not yet paid as of the “short-term deferral
date” shall be paid in a lump sum on the “short-term deferral date.” The “short-term deferral date” is the date that is two and one-half months after the end of the later of (i) the calendar year containing the Date of
Termination or (ii) the Company’s fiscal year containing the Date of Termination. Such payment shall be paid to Executive within 30 days after the Date of Termination. 

 

	 	(c)	To the extent not theretofore paid or provided, the Affiliated Group shall pay or provide, or cause to be paid or provided, to the Executive any other amounts or
benefits required to be paid or provided or which the Executive is eligible to receive under any plan, program, policy or practice or contract or agreement of the Affiliated Group (such other amounts and benefits shall be hereinafter referred to as
the “Other Benefits”), in accordance with the terms and normal procedures of each such plan, program, policy or practice or contract or agreement, based on accrued and vested benefits through the Date of Termination.

  

	 	(d)	If the Date of Termination occurs within six months after the occurrence of a Change in Control, any stock options to purchase shares of the common stock of Patheon
then held by the Executive shall, to the extent not otherwise provided in the applicable Stock Related Documents, become immediately vested and exercisable and shall remain exercisable for a period of (12) months from the Date of Termination.

  
 Page 8

 If the Executive receives payments and benefits pursuant to this Section 5.1, then the
Executive shall not be entitled to any other severance pay or benefits under any severance plan, program or policy of any member of the Affiliated Group, unless otherwise specifically provided therein in a specific reference to this Agreement.

  

	5.2	Death or Disability; Cause; Other than for Good Reason  

 If the Executive’s employment is terminated due to death or Disability or for Cause, or if the Executive voluntarily terminates his employment without Good Reason, this Agreement shall terminate
without further obligations to the Executive other than the obligation to pay to the Executive his Accrued Obligations through the Date of Termination and the Other Benefits, in each case to the extent not theretofore paid or provided. Subject to
any withholding required by Section 3.3, all Accrued Obligations shall be paid to the Executive in accordance with Section 5.1(a) and the Other Benefits shall be paid to the Executive in accordance with Section 5.1(c). 

 

	5.3	Release 

Notwithstanding anything contained herein to the contrary, the Corporation shall only be obligated to make the payments under
Section 5.1(b) if: (a) within the 50-day period after the Date of Termination, the Executive executes a general release, in a form provided by the Corporation, of all current or future claims, known or unknown, against the Affiliated
Group, its officers, directors, shareholders, employees and agents arising on or before the date of the release, including but not limited to all claims arising out of the Executive’s employment with the Affiliated Group or the termination of
such employment, and (b) the Executive does not revoke the release during the seven-day revocation period prescribed by the Age Discrimination in Employment Act of 1967, as amended, or any similar revocation period, if applicable. The
Corporation shall be obligated to provide such release to the Executive promptly following the Date of Termination. 
 ARTICLE
6 
 RESTRICTIVE COVENANTS 
  

	6.1	In General  

 The
Executive acknowledges that in the course of his employment he will become familiar with trade secrets and customer lists of and other confidential information concerning the Affiliated Group and that his services have been of special, unique and
extraordinary value to the Affiliated Group. 
  

	6.2	Confidentiality Undertaking  

 The Executive confirms that he is bound by the provisions of the Confidentiality Undertaking covenant set out in Schedule B hereto. 

 

	6.3	Non-Solicitation/No-Hire 

  

	 	(a)	During the 12-month period immediately following the Date of Termination, the Executive shall not in any manner, directly or indirectly, hire, solicit, induce or
attempt to solicit or induce any employee of any member of the Affiliated Group to quit or abandon his or her employ or to become an officer, agent, employee, partner, director, consultant or independent contractor of the Executive, his affiliates
or any other individual or entity. 

  
 Page 9

	 	(b)	During the 12-month period immediately following the Date of Termination, the Executive shall not in any manner, directly or indirectly, hire, solicit, induce or
attempt to solicit or induce, any customer, supplier or licensor of any member of the Affiliated Group to cease doing business with any member of the Affiliated Group, or in any way interfere with the relationships between any customer, supplier or
licensor of the Affiliated Group. 

  

	6.4	Non-Competition 

 During the
12-month period immediately following the Date of Termination, the Executive shall not in any manner, directly or indirectly, compete with the business of any member of the Affiliated Group by (a) becoming an officer, agent, employee, partner,
director, consultant, independent contractor of a Competitor, or (b) acquiring an ownership interest in a Competitor, provided that the Executive may, for investment purposes, own not more than 1% of the outstanding stock of any class of a
Competitor that is listed on a recognized stock exchange or traded in the over-the-counter market in Canada or the United States. For purposes of this Agreement, the term “Competitor” shall mean any person or entity whose primary business
is in contract pharmaceutical development, pharmaceutical contract manufacturing and/or packaging for pharmaceutical products and/or clinical drug supplies in Canada, the United States (including the Commonwealth of Puerto Rico), India or Europe.

  

	6.5	Reasonableness and Revision 

 The Executive agrees and acknowledges that due to the uniqueness of his services and the confidential nature of the information he will possess, the covenants set forth in this Article 6 and Schedule B
are reasonable and necessary for the protection of the business interests and goodwill of the Affiliated Group. Moreover, the geographic restriction on competitive activities by the Executive is reasonable, given the global nature of the Affiliated
Group’s business and the Executive’s role in that business. If, at the time of enforcement of this Article and/or Schedule B, a court or other tribunal holds that the restrictions herein are in whole or in part unreasonable under
circumstances then existing, the parties agree that the maximum period or scope reasonable under such circumstances will be substituted for the stated period or scope and that the court or other tribunal shall be authorized and directed by the
parties to revise the restrictions contained herein to cover the maximum period or scope permitted by law. 
  

	6.6	Acknowledgements 

The Executive agrees and acknowledges that the promises and obligations made by the Corporation in this Agreement (specifically including,
but not limited to, the payments and benefits provided for under Section 5.1(b) and (d) hereof) constitute sufficient consideration for the covenants contained in this Article 6. The Executive further acknowledges that it is not the
Affiliated Group’s intention to interfere in any way with his employment opportunities, except in such situations where the same conflict with the legitimate business interests of the Affiliated Group. The Executive agrees that he will notify
the Corporation in writing if he has, or reasonably should have, any questions regarding the applicability of this Article 6. 
  

	6.7	Enforcement 

  

  
 Page 10

 Because the Executive’s services are unique and because the Executive has access to
Confidential Information and work product, the parties agree that the Affiliated Group will be damaged irreparably in the event any of the provisions of Section 6.2, 6.3 and 6.4 are not performed in accordance with their specific terms or are
otherwise breached and that money damages will be an inadequate remedy for any such non-performance or breach. Therefore, any one or more of the members of the Affiliated Group, or their respective successors and assigns, will be entitled, in
addition to other rights and remedies existing in their favor, to an injunction or injunctions to prevent any breach or threatened breach of any of such provisions and to enforce such provisions specifically (without posting a bond or other
security). The Executive agrees and acknowledges that he will not assert in any such enforcement action that there is an adequate remedy in damages and that such rights and remedies will be in addition to and not in lieu of any other rights or
remedies available to the Affiliated Group at law or in equity. 
  

	6.8	Survival  

 Subject
to any limits on applicability contained therein, this Article 6 shall survive and continue in full force in accordance with its terms notwithstanding any expiration or termination of this Agreement. 

ARTICLE 7 

GENERAL PROVISIONS 
  

	7.1	Entire Agreement 

This Agreement together with Schedules A and B attached hereto when executed by both parties shall constitute the entire agreement
pertaining to the Executive’s employment and supersedes all prior agreements, understandings, negotiations and discussions, whether written or oral, pertaining to the Executive’s employment, and there are no representations, undertakings
or agreements of any kind between the parties respecting the subject matter hereof except those contained herein. 
  

	7.2	Severability  

 If
any provision of this Agreement is declared void or unenforceable, such provision shall be deemed severed from this Agreement to the extent of the particular circumstances giving rise to such declaration and such provision as it applies to other
persons and circumstances and the remaining terms and conditions of this Agreement shall remain in full force and effect. 
  

	7.3	Representations 

The Executive represents and warrants that (a) he is not a party to any contract, understanding, agreement or policy, whether or not
written, with his current employer (or any previous employer) or otherwise, that would be breached by the Executive’s entering into, or performing services under, this Agreement and (b) will not knowingly use any trade secret, confidential
information, or other intellectual property right of any other party in the performance of his duties hereunder. The Executive will indemnify, defend, and hold each member of the Affiliated Group harmless, from any and all suits and claims arising
out of any breach of such restrictive contracts, understandings, agreements or policies. 
  

	7.4	Notices 

  
 Page 11

 All notices and other communications hereunder shall be in writing and shall be given by
hand delivery to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows: 
 If to the Executive: 
 Peter T. Bigelow, P.E. 

60 Diamond Road 

Phoenixville, PA 19460-2780 
 If to the Corporation: 
 Attention: 

Executive Human Resources 
 Patheon Pharmaceutical Services Inc. 
 P.O. Box 110145 

Research Triangle Park, North Carolina 27709-9998 
 or to such other address as either party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually received by the addressee.

  

	7.5	Withholding 

 The
Corporation may withhold from any amounts payable under this Agreement such Federal, state, local, foreign or other taxes as shall be required to be withheld pursuant to any applicable law or regulation. 

 

	7.6	Waiver 

 The
Executive’s or the Corporation’s failure to insist upon strict compliance with any provision of this Agreement or the failure to assert any right the Executive or the Corporation may have hereunder, including, without limitation, the right
of the Executive to terminate employment for Good Reason, shall not be deemed to be a waiver of such provision or right or any other provision or right of this Agreement. 

 

	7.7	Successors 

  

	 	(a)	This Agreement is personal to the Executive is not assignable by the Executive. This Agreement shall inure to the benefit of and be enforceable by the Executive’s
legal representatives. This Agreement shall inure to the benefit of and be binding upon the Corporation, the other members of the Affiliated Group, and their respective successors and assigns. 

 

	 	(b)	 The Corporation will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of
the business and/or assets of Patheon or the Corporation to assume expressly and agree to perform this Agreement in the same manner and to the same extent that 

  
 Page 12

 
the Corporation would be required to perform if no such succession had taken place. 
  

	7.8	Compliance with Section 409A of the Code 

  

	 	(a)	It is the Corporation’s intent that the payments and benefits provided under this Agreement shall be exempt from the application of, or otherwise comply with, the
requirements of Section 409A of the Code (“Section 409A”). Specifically, any taxable benefits or payments provided under this Agreement are intended to be separate payments that qualify for the “short-term deferral”
exception to Section 409A to the maximum extent possible, and to the extent they do not so qualify, are intended to qualify for the involuntary separation pay exceptions to Section 409A to the maximum extent possible. This Agreement shall
be construed, administered, and governed in a manner that effects such intent, and the Corporation shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the payments and benefits provided under this
Agreement may not be deferred, accelerated, extended, paid out or modified in a manner that would result in the imposition of an additional tax under Section 409A upon the Executive. 

 

	 	(b)	If neither the “short-term deferral” or the involuntary separation pay exceptions to Section 409A described above applies to a benefit, payment or
reimbursement under this Agreement, then notwithstanding any provision in this Plan to the contrary, the remaining provisions of this Section 7.8(b) shall apply. 

 

	 	(i)	If the Executive is a “specified employee,” as determined under the Corporation’s policy for identifying specified employees on the Date of Termination,
then to the extent required in order to comply with Section 409A of the Code, all payments, benefits or reimbursements paid or provided under this Agreement that constitute a “deferral of compensation” within the meaning of
Section 409A of the Code, that are provided as a result of a “separation from service” within the meaning of Section 409A and that would otherwise be paid or provided during the first six months following such Date of Termination
shall be accumulated through and paid or provided (together with interest on the delayed amount at the applicable federal rate under Section 7872(f)(2)(A) of the Code in effect on the Date of Termination) within 30 days after the first business
day following the six month anniversary of such Date of Termination (or, if the Executive dies during such six-month period, within 30 days after the Executive’s death). 

 

	 	(ii)	To the extent required to comply with Section 409A Code, any reimbursement of expenses pursuant to Section 2.4(b), 2.4(c) or 3.8, that will not be excluded
from Executive’s income when received is subject to the following requirements: (i) the amount of expenses eligible for reimbursement during a calendar year may not affect the expenses eligible for reimbursement, or in-kind benefits to be
provided in any other calendar year; (ii) the reimbursement of the eligible expense must be made on or before the last day of the calendar year following the calendar year in which the expense was incurred; and (iii) the right to
reimbursement is not subject to liquidation or exchange for another benefit. 

  
 Page 13

	 	(c)	Although the Corporation shall use its best efforts to avoid the imposition of taxation, interest and penalties under Section 409A of the Code, the tax treatment
of the benefits provided under this Agreement is not warranted or guaranteed. Neither the Affiliated Group nor its directors, officers, employees or advisers shall be held liable for any taxes, interest, penalties or other monetary amounts owed by
the Executive or other taxpayer as a result of the Agreement. Any reference in this Agreement to Section 409A of the Code will also include any proposed, temporary or final regulations; or any other guidance, promulgated with respect to such
Section 409A by the U.S. Department of Treasury or the Internal Revenue Service. 

 NOW THEREFORE, the
parties below have entered into this Agreement as of the date first written above. 
 PATHEON PHARMACEUTICAL SERVICES INC. 

/s/ Wes Wheeler 
 By: Wes Wheeler 

Title: Chief Executive Officer and President 
  

							
	SIGNED, SEALED AND DELIVERED	  	)	  		  	
	 in the presence of
	  	)	  		  	
		  	)	  		  	
	 /s/ Mitchell Wienick
	  	)	  	 /s/ Peter T. Bigelow
	  	
	Name of Witness: Mitchell Wienick	  		  	Peter T. Bigelow	  	
		  		  	Jan 7, 2010	  	

  
 Page 14

 [PATHEON] 
 SCHEDULE A 
 TO 

EMPLOYMENT AGREEMENT WITH 
 Peter T. Bigelow 
  
 PATHEON INC. 
 POSITION DESCRIPTION 

President, North American Operations 
 The responsibilities will include all necessary to operate, grow and successfully lead the six operating facilities in this region: Cincinnati, Toronto, Whitby, Burlington. Caguas and Manati. You will be
responsible for negotiating new contracts, extend existing contracts, optimizing your business and maximizing EBITDA and operating cashflow. You will have a P&L, balance sheet and cash flow to manage. You will also be asked to locate and acquire
new plants, work with large pharma companies as they re-structure their own networks and find opportunities. 
 Operational duties and
responsibilities include: 
  

	 	•	 	 The execution of corporate plans and strategies as they relate to areas of operation responsibility. 

 

	 	•	 	 The development of appropriate operating strategies to support the Patheon business plans and growth initiatives. 

 

	 	•	 	 The overall management of all Canadian and US Sites, working closely with each Site Executive Director and GM. 

 

	 	•	 	 Ensuring that Patheon’s Canadian and US operations have adequate physical and human resource capacity to meet client needs and support
Patheon’s growth objectives. 

  

	 	•	 	 The development and management of Canadian and US Site operating budgets and capital expenditure programs. 

 

	 	•	 	 The development and monitoring of programs and actions needed to ensure that each Canadian and US site operates in compliance with cGMP’s, client
requirements and Patheon’s quality policies and goals. 

  

	 	•	 	 The overall responsibility for client service functions at all Canadian and US sites to ensure that each site achieves and consistently maintains
exceptional client service levels. 

  

	 	•	 	 The development and maintenance of each Canadian and US site as a client oriented operating business unit in accordance with the Patheon operating
philosophy. 

  

	 	•	 	 The participation, with other members of Patheon’s Executive Management Team, in presentations and preparation of proposals to prospective
clients. Primary responsibility for the development and implementation of the operating plans needed to support new business opportunities. 

  

	 	•	 	 Membership on the Executive Committee. 

 December 18, 2009 

  
 Page 15

 [PATHEON] 
 SCHEDULE B 
 TO 

EMPLOYMENT AGREEMENT WITH 
 Peter T. Bigelow 
  

 
 CONFIDENTIALITY UNDERTAKING

 In consideration of Peter T. Bigelow (the “Executive”) accepting an employment agreement between the Executive and Patheon
Pharmaceuticals Services Inc. dated December 18, 2009 (the “Agreement”) to which this Confidentiality Undertaking is attached as Schedule B, the Executive undertakes and covenants with the Affiliated Group (as defined in the
Agreement) as follows: 
  

	1.	CONFIDENTIAL INFORMATION  

  

	1.1	Confidential Information  

 The Executive
acknowledges that all information and facts relating to the business and affairs of the Affiliated Group and its customers, including, without limitation, trade secrets, data, notes, marketing plans, sales patterns, and private corporate and
financial information (the “Confidential Information”) is confidential and proprietary to the Affiliated Group and a valuable trade secret of the Affiliated Group, disclosure of which could severely damage the economic interests of
the Affiliated Group. Confidential Information includes, without limitation, any document, work, instrument or other medium assembled or composed by the Executive which contains Confidential Information. 

 

	1.2	Non-Disclosure of Confidential Information 

The Executive shall not, either during the term of the Agreement or at any time thereafter. use or disclose, directly or indirectly, any of such
Confidential Information to any person outside the Affiliated Group, except where such disclosure is necessary for the proper and bona fide execution of the Executive’s duties under the Agreement, without the prior written consent of the
Affiliated Group. The Executive’s obligation not to use or disclose Confidential Information without prior written consent shall continue to apply after the Executive has ceased to be an employee of the Affiliated Group until such time as the
Confidential Information becomes public knowledge through no fault of the Executive. The Affiliated Group will have full right, title and authority to deal in and with the proprietary rights and the Confidential Information notwithstanding any other
provision of the Agreement or the termination thereof for any reason whatsoever. The Executive acknowledges and agrees that the restrictions contained in this Article 1 are reasonable in the circumstances in order to protect the business of the
Affiliated Group. 
  

	1.3	Return of Confidential Information 

Confidential Information and the documents, works, instruments or other media containing Confidential Information shall remain the property of the
Affiliated Group and be returned to the Affiliated Group upon request or immediately following termination of the Agreement for any reason whatsoever. 

  
 Page 16

	2.	INVENTIONS 

  

	2.1	Inventions 

 Subject to Section 2.2,
the Executive agrees that all discoveries, improvements, designs, ideas or inventions made or conceived, in whole or in part, by the Executive during the term of the Agreement or within three years following termination of the Agreement for any
reason whatsoever (the “Inventions”) shall be the sole property of the Affiliated Group. The Executive shall: 
  

	 	(a)	promptly disclose and describe all such Inventions in writing to the Affiliated Group; 

 

	 	(b)	assign, and the Executive does hereby assign, to the Affiliated Group, without further compensation, all of the Executive’s rights, title and interest in and to
such Inventions and to all applications for letters of patent, copyrights, industrial design or other forms of protection granted for such Inventions throughout the world; 

 

	 	(c)	deliver promptly to the Affiliated Group, upon request and in the form and manner prescribed by the Affiliated Group (without charge to the Affiliated Group but at the
Affiliated Group’s expense) the written instruments described in paragraph (b) and perform such acts as deemed necessary by the Affiliated Group to obtain and maintain such instruments and to transfer all rights and title thereto to the
Affiliated Group; and 

  

	 	(d)	give all assistance that may be required by the Affiliated Group to enable it to protect or exploit the Inventions in any country of the world.

 The Executive does hereby waive in whole any moral rights that the Executive may have in each of the Inventions and any part or
parts thereof, including, but not limited to, the right to the integrity of the Inventions, the right to be associated with the Inventions as its author by name or under a pseudonym and the right to remain anonymous. 

 

	2.2	Excluded Inventions 

 The provisions of
Section 2.1 shall not apply to Inventions which fulfill all of the following criteria: 
  

	 	(a)	Inventions for which no equipment, supplies, facility or Confidential Information belonging to the Affiliated Group were used; and 

 

	 	(b)	Inventions that do not relate to the business of the Affiliated Group or to the Affiliated Group’s actual or demonstrably anticipated processes, research or
development which the Executive had access to or knowledge of; and 

  

	 	(c)	Inventions that do not result from any work performed by the Executive for the Affiliated Group. 

 

	3.	GENERAL 

 This Confidentiality Undertaking
shall be governed and construed in accordance with the laws of North Carolina applicable therein. Nothing herein shall be construed so as to limit any obligations owed by you to the Affiliated Group as a matter of common law. The Executive
acknowledges that the business of the Affiliated Group cannot be properly protected from 

  
 Page 17

 
adverse consequences of the Executive’s actions other than by the restrictions set forth in this Undertaking and the Agreement. The Affiliated Group, in addition to any other right or relief
to which it may be entitled, shall be entitled to an injunction restricting further breaches of this Undertaking or the Agreement. This Confidentiality Undertaking shall survive the termination of the Agreement and the Executive’s employment
thereunder. 
 IN WITNESS WHEREOF this Confidentiality Undertaking has been executed by the undersigned on this 07 day of Jan, 2010. 

 

									
	SIGNED, SEALED AND DELIVERED	  	)	  		  		  	
	 in the presence of
	  	)	  		  		  	
		  	)	  		  		  	
	  
	  	)	  		  	 /s/ Peter T. Bigelow
	  	
	Name of Witness:	  		  		  	 Peter T. Bigelow
	  	

  
 Page 18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}]]